Raphael Pharmaceutical, Inc. (RAPH)
1.51
0.00 (0.00%)
USD |
OTCM |
Nov 03, 16:00
Raphael Pharmaceutical EPS Diluted (Quarterly) : -0.0111 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.0111 |
| March 31, 2026 | -0.0114 |
| December 31, 2025 | -0.0137 |
| September 30, 2025 | -0.013 |
| June 30, 2025 | -0.0164 |
| March 31, 2025 | -0.0219 |
| December 31, 2024 | -0.0211 |
| September 30, 2024 | -0.0174 |
| June 30, 2024 | -0.0133 |
| March 31, 2024 | -0.0295 |
| December 31, 2023 | 0.0034 |
| Date | Value |
|---|---|
| September 30, 2023 | -0.0441 |
| June 30, 2023 | -0.0259 |
| March 31, 2023 | -0.0165 |
| December 31, 2022 | -0.0706 |
| September 30, 2022 | -0.0932 |
| June 30, 2022 | -0.0412 |
| March 31, 2022 | -0.0122 |
| September 30, 2021 | -0.0343 |
| June 30, 2021 | -0.0254 |
| March 31, 2021 | -0.0168 |
| September 30, 2020 | -0.0257 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| InterCure Ltd. | -- |
| IM Cannabis Corp. | -0.3399 |
| Teva Pharmaceutical Industries Ltd. | -0.5029 |
| RedHill Biopharma Ltd. | -- |
| MediWound Ltd. | -0.5737 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -0.223M |
| Total Expenses (Quarterly) | 0.223M |
| Enterprise Value | 30.51M |
| Earnings Yield | -3.26% |
| Normalized Earnings Yield | -3.252 |